JSE- and NYSE-listed Sibanye expects to report an attributable loss of at least R4.8-billion for the six months to June 30, mainly as a result of R4.4-billion in nonrecurring items, including a R1.1-billion provision for potential silicosis claims. Also part of the nonrecurring items is a R2.8-billion impairment charge relating to the cessation of its lossmaking Cooke and Beatrix West operations and R402-million in costs associated with the acquisition of US firm Stillwater Mining Company. Earnings were also negatively impacted on by the 14% appreciation of the rand against the dollar during the period under review.
